FOGHORN THERAPEUTICS INC (FHTX)

US3441741077 - Common Stock

5.51  -0.3 (-5.16%)

After market: 5.51 0 (0%)

Unregistered users can only see 4 years or quarters

Examples of complete financials are available for MSFT and AAPL.

Please register or login for additional data.

TTM
(2024-3-31)
2023
(2023-12-31)
2022
(2022-12-31)
2021
(2021-12-31)
2020
(2020-12-31)
CASH FLOWS FROM OPERATING ACTIVITIES
Net Income
-92.92M-98.43M-108.90M-101.30M-68.80M
Depreciation Amortization
3.39M3.45M3.30M3.20M1.30M
Change In Working Capital
-44.53M-41.88M281.50M33.40M28.70M
Interest Paid
N/AN/A0.001.70M700.00K
Taxes Paid
N/A3.55MN/AN/AN/A
Other non cash items
17.84M18.75M17.60M14.40M7.50M
OPERATING CASH FLOW
-116.25M-118.11M193.60M-50.30M-31.30M
 
CASH FLOWS FROM INVESTING ACTIVITIES
Capital Expenditure
-725.00K-1.22M-1.20M-3.30M-16.20M
Other Investing Activity
142.77M145.67M-243.10M39.50M-92.70M
INVESTING CASH FLOW
142.04M144.45M-244.30M36.20M-108.90M
 
CASH FLOWS FROM FINANCING ACTIVITIES
Debt Issued/Reduced
N/AN/A0.00-21.20M4.30M
Stock Issued/Repurchased
2.85M1.78M1.80M1.40M213.20M
Other Financing Activity
N/AN/A0.0042.20MN/A
FINANCING CASH FLOW
2.85M1.78M1.80M22.40M217.50M
 
CHANGE IN CASH
28.64M28.12M-48.90M8.30M77.30M
 
FREE CASH FLOW
Operating Cash Flow
-116.25M-118.11M193.60M-50.30M-31.30M
Capital Expenditure
-725.00K-1.22M-1.20M-3.30M-16.20M
FREE CASH FLOW
-116.98M-119.33M192.40M-53.60M-47.50M

All data in USD

Charts